Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas
information for practice,
This study aimed at applying the restricted mean survival time difference (rmstD) as an absolute outcome measure in a network…